HUM
33
2
CMG
69
-4
MHK
31
-3
AAPL
64
11
CCL
68
-2
SLG
57
4
PYPL
62
2
AAP
29
-3
INTU
59
-3
VRSK
63
-3
HAS
32
-5
CA
25
-7
IR
55
-3
EMR
64
-3
FLS
69
-2
BIIB
38
-2
PSA
48
-2
FCX
50
-2
CVS
31
2
STZ
54
2
HUM
33
2
CMG
69
-4
MHK
31
-3
AAPL
64
11
CCL
68
-2
SLG
57
4
PYPL
62
2
AAP
29
-3
INTU
59
-3
VRSK
63
-3
HAS
32
-5
CA
25
-7
IR
55
-3
EMR
64
-3
FLS
69
-2
BIIB
38
-2
PSA
48
-2
FCX
50
-2
CVS
31
2
STZ
54
2
Financhill
Back

Vaxcyte Quote, Financials, Valuation and Earnings

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Sell
47

PCVX
Vaxcyte

Last Price:
87.80
Seasonality Move:
4.67%

7 Day Trial

ALL ACCESS PASS

$ 7

The dark truth about AI

Click here to learn more...

Vaxcyte Price Quote

$87.80
+0.08 (+-0.08%)
(Updated: December 14, 2024 at 5:46 AM ET)

Vaxcyte Key Stats

Sell
47
Vaxcyte (PCVX) is a Sell
Day range:
$86.80 - $89.65
52-week range:
$53.83 - $121.06
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.2%
Volume:
958.6K
Avg. volume:
1.4M
1-year change:
48.08%
Market cap:
$11B
Revenue:
$0
EPS:
$-4.6

How Much Does Vaxcyte Make?

Data Unavailable

Is Vaxcyte Growing As A Company?

Data Unavailable

Vaxcyte Stock Price Performance

  • Did Vaxcyte Stock Go Up Last Month?
    Vaxcyte share price went down by -9.22% last month
  • Did PCVX's Share Price Rise Over The Last Year?
    PCVX share price rose by 48.08% over the past 1 year

What Is Vaxcyte 52-Week High & Low?

  • What Is Vaxcyte’s 52-Week High Share Price?
    Vaxcyte has traded as high as $121.06 over the past 52 weeks
  • What Is Vaxcyte’s 52-Week Low Share Price?
    Vaxcyte has traded as low as $53.83 over the past 52 weeks

Vaxcyte Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vaxcyte?

  • How Much Debt Does Vaxcyte Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Vaxcyte Have?
    Cash and short term investments quarterly total is $2.2B
  • What Is Vaxcyte’s Book Value Per Share?
    Book value per share is 27.47

Is Vaxcyte Cash Flow Positive?

  • What Is PCVX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$470M
  • What Is Vaxcyte’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $2.4B
  • What Is Vaxcyte’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.5B

Vaxcyte Return On Invested Capital

Data Unavailable

Vaxcyte Earnings Date & Stock Price

  • What Is Vaxcyte's Stock Price Today?
    A single share of PCVX can be purchased today for 87.72
  • What Is Vaxcyte’s Stock Symbol?
    Vaxcyte trades on the nasdaq under the ticker symbol: PCVX
  • When Is Vaxcyte’s Next Earnings Date?
    The next quarterly earnings date for Vaxcyte is scheduled on February 27, 2025
  • When Is PCVX's next ex-dividend date?
    Vaxcyte's next ex-dividend date is December 15, 2024
  • How To Buy Vaxcyte Stock?
    You can buy Vaxcyte shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Vaxcyte Competitors

  • Who Are Vaxcyte's Competitors?
    Below is a list of companies who compete with Vaxcyte or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • CEL-SCI Corp (CVM)
    • IGC Pharma Inc (IGC)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Protalix BioTherapeutics Inc (PLX)

Vaxcyte Dividend Yield

  • What Is PCVX Dividend Yield?
    Vaxcyte’s dividend yield currently is 0%
  • What Is Vaxcyte’s Payout Ratio?
    Vaxcyte’s payout ratio is 0%
  • When Did Vaxcyte Last Pay A Dividend?
    The latest dividend pay date is December 15, 2024
  • What Is Vaxcyte’s Dividend Per Share?
    Vaxcyte pays a dividend of $0.00 per share

Vaxcyte Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 16.13%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 9
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 151.75
Upside from Last Price: 72.99%

Major Shareholders

  • How many PCVX shares are owned by institutional investors?
    242.6M PCVX shares are owned by institutional investors
  • How many PCVX shares are owned by insiders?
    1M PCVX shares are owned by insiders